Literature DB >> 3085140

Comparison of the metabolism of the three antidepressants amitriptyline, imipramine, and chlorimipramine in vitro in rat liver microsomes.

R Krüger, G Hölzl, H J Kuss, L Schefold.   

Abstract

The metabolism of the tricyclic antidepressants amitriptyline (AMI), imipramine (IMI), chlorimipramine (CMI) and some of their metabolites was studied in vitro in isolated liver microsomes of female Spraque-Dawley rats. Nine metabolites of AMI, seven metabolites of IMI, and 11 metabolites of CMI were quantitatively determined with high-performance liquid chromatography. The main metabolic reactions, mediated by an NADPH generating system, were hydroxylation, demethylation, and N-oxidation. The ratio of these reactions was different for the three drugs. AMI was hydroxylated more than CMI and CMI more than IMI. The order for demethylation was CMI greater than AMI = IMI, the order for N-oxidation IMI greater than CMI less than or equal to AMI. The substrate dependence of metabolism was investigated. Demethylation and N-oxidation increased proportionally to increasing substrate concentrations, whereas formation of hydroxylated metabolites became saturated (in the concentration range of 10(-6)-10(-5) M). The in vitro metabolism was compared with the in vivo metabolism in humans, reflected by the plasma concentrations of these drugs and their metabolites. A good agreement in metabolic pathways was found.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3085140     DOI: 10.1007/bf00178516

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  37 in total

1.  New metabolites of imipramine.

Authors:  J L Crammer; B Scott
Journal:  Psychopharmacologia       Date:  1966

2.  Binding and oxidation of amitriptyline and a series of its oxidized metabolites in liver microsomes from untreated and phenobarbital-treated rats.

Authors:  C von Bahr
Journal:  Xenobiotica       Date:  1972-05       Impact factor: 1.908

3.  Spectral studies on the interaction of imipramine and some of its oxidized metabolites with rat liver microsomes.

Authors:  C von Bahr; S Orrenius
Journal:  Xenobiotica       Date:  1971-01       Impact factor: 1.908

4.  Studies on the demethylation, hydroxylation and N-oxidation of imipramine in rat liver.

Authors:  K Nakazawa
Journal:  Biochem Pharmacol       Date:  1970-04       Impact factor: 5.858

5.  Hydroxylated metabolites of tricyclic antidepressants: preclinical assessment of activity.

Authors:  W Z Potter; H M Calil; A A Manian; A P Zavadil; F K Goodwin
Journal:  Biol Psychiatry       Date:  1979-08       Impact factor: 13.382

6.  The metabolism of imipramine and its metabolites by rat liver microsomes.

Authors:  M H Bickel; M Baggiolini
Journal:  Biochem Pharmacol       Date:  1966-08       Impact factor: 5.858

7.  E- and Z-10-hydroxylation of nortriptyline: relationship to polymorphic debrisoquine hydroxylation.

Authors:  B Mellström; L Bertilsson; J Säwe; H U Schulz; F Sjöqvist
Journal:  Clin Pharmacol Ther       Date:  1981-08       Impact factor: 6.875

Review 8.  Human cytochromes P-450.

Authors:  A R Boobis; D S Davies
Journal:  Xenobiotica       Date:  1984 Jan-Feb       Impact factor: 1.908

9.  Phase I metabolism of imipramine by microsomes of small intestine in comparison with metabolism by liver microsomes.

Authors:  W Christ; W Hecker; H Junge; G Stille
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1983-06       Impact factor: 3.000

10.  SPECIES DIFFERENCES IN THE METABOLISM OF IMIPRAMINE AND DESMETHYLIMIPRAMINE (DMI).

Authors:  J V DINGELL; F SULSER; J R GILLETTE
Journal:  J Pharmacol Exp Ther       Date:  1964-01       Impact factor: 4.030

View more
  4 in total

1.  Inhibition of antidepressant demethylation and hydroxylation by fluvoxamine in depressed patients.

Authors:  S Härtter; H Wetzel; E Hammes; C Hiemke
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

Review 2.  Clinical pharmacokinetics of imipramine and desipramine.

Authors:  F R Sallee; B G Pollock
Journal:  Clin Pharmacokinet       Date:  1990-05       Impact factor: 6.447

3.  Plasma and brain pharmacokinetics of amitriptyline and its demethylated and hydroxylated metabolites after acute intraperitoneal injection in mice.

Authors:  F Coudore; J Fialip; A Eschalier; J Lavarenne
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1994 Jan-Mar       Impact factor: 2.441

4.  Bioequivalence Study of Amitriptyline Hydrochloride Tablets in Healthy Chinese Volunteers Under Fasting and Fed Conditions.

Authors:  You Zhai; Lihua Wu; Yunliang Zheng; Minglan Wu; Yujie Huang; Qian Huang; Jianzhong Shentu; Qingwei Zhao; Jian Liu
Journal:  Drug Des Devel Ther       Date:  2020-08-04       Impact factor: 4.162

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.